on The Vanguard Group, Inc. (isin : US12572Q1058)
The Vanguard Group Discloses Position in Mural Oncology
The Vanguard Group, Inc. has made a disclosure under Rule 8.3 of the Irish Takeover Panel Act, 1997. This involves its position in Mural Oncology plc. The information was released on September 9, 2025.
The disclosure identifies The Vanguard Group as holding interests of 4.47% in $0.01 ordinary shares of Mural Oncology plc. However, it notes no positions in cash-settled or stock-settled derivatives. A recent sale involved 16 ordinary shares at $2.07 per share.
The disclosure reports no indemnity or option arrangement agreements related to the securities of Mural Oncology and no supplemental forms were attached. Shawn Acker is listed as the contact person for this disclosure.
R. H.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all The Vanguard Group, Inc. news